Drug Trial Results: Positive data boosts investor confidence, driving up demand and price. Negative results can lead to a sell-off and price decline.

Regulatory Approvals: Approval by major regulatory bodies (e.g., FDA, EMA) signals market access and future revenue, increasing the stock price. Rejections or delays negatively impact the price.

Competition: Entry of new competitors or availability of alternative treatments can erode market share and lower the price. Absence of competition or patent protection can maintain high prices.

Market Conditions: Overall economic health, investor sentiment, and broader market trends influence AZT.OL's stock performance. A bull market often lifts all stocks, while a bear market can depress them.

Company Performance: Revenue growth, profitability, and successful product launches directly impact investor perception and stock price. Poor financial performance can trigger a price decline.

Patent Expiry: Loss of patent protection allows generic competition, significantly reducing sales and impacting the stock price negatively.

News and Events: Major announcements, acquisitions, partnerships, and significant healthcare events (e.g., pandemics) can cause volatility in the stock price.

Global Health Crises: Outbreaks or global health emergencies can increase demand for certain drugs, potentially boosting AZT.OL's stock price if they are relevant.

Government Regulations: Changes in healthcare policies, pricing regulations, and reimbursement policies can affect the profitability and stock price of pharmaceutical companies.

Interest Rates: Higher interest rates can make borrowing more expensive, impacting company growth and potentially lowering the stock price.

Investor Sentiment: Positive investor sentiment can drive up demand and price, while negative sentiment can lead to selling pressure and a price decline.

Manufacturing Issues: Production delays, quality control problems, or supply chain disruptions can negatively impact revenue and stock price.